We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.34B
1-Year Est. Return
204.53%
This Fund
S&P 500
This Quarter
Est. Return
+0.5%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$3.29B
AUM Growth
-$101M
(-3%)
Cap. Flow
+$25.6M
Cap. Flow
% of AUM
0.78%
Top 10 Holdings %
Top 10 Hldgs %
70.15%
Holding
84
New
9
Increased
10
Reduced
4
Closed
18
Top Buys
| 1 |
Revolution Medicines
RVMD
|
+$56.5M |
| 2 |
Adicet Bio
ACET
|
+$55.5M |
| 3 |
Zymeworks
ZYME
|
+$53.2M |
| 4 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
+$36.9M |
| 5 |
Dyne Therapeutics
DYN
|
+$26.9M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$70.9M |
| 2 |
Gossamer Bio
GOSS
|
+$49.8M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$47.3M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$39.1M |
| 5 |
Design Therapeutics
DSGN
|
+$22.1M |
Sector Composition
| 1 | Healthcare | 99.78% |
| 2 | Financials | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Prothena Corp
PRTA
$441M
| $698M | 21.24% |
11,584,280
| – | – |
|
2
Sarepta Therapeutics
SRPT
$1.86B
| $389M | 11.83% |
2,999,453
| – | – |
|
|
APLS
3
DELISTED
Apellis Pharmaceuticals
APLS
| $268M | 8.16% |
5,183,431
| – | – |
|
4
AnaptysBio
ANAB
$1.65B
| $233M | 7.09% |
7,521,024
| – | – |
|
|
LKFT
5
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $166M | 5.04% |
3,730,730
+533,230
| +17% | +$22.4M |
|
6
Xencor
XNCR
$1.11B
| $138M | 4.19% |
5,282,516
| – | – |
|
7
Arvinas
ARVN
$534M
| $107M | 3.25% |
3,123,300
| – | – |
|
|
8
Revolution Medicines
RVMD
$39.2B
| $106M | 3.23% |
4,458,731
+2,656,884
| +147% | +$56.5M |
|
|
MORF
9
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $106M | 3.22% |
3,951,566
| – | – |
|
10
Acadia Pharmaceuticals
ACAD
$4.44B
| $95.4M | 2.9% |
5,991,479
| – | – |
|
|
SWTX
11
DELISTED
SpringWorks Therapeutics
SWTX
| $90M | 2.74% |
3,460,208
| – | – |
|
12
Kura Oncology
KURA
$1.01B
| $82.4M | 2.51% |
6,638,371
| – | – |
|
13
Zai Lab
ZLAB
$2.31B
| $66.2M | 2.02% |
2,157,686
+127,434
| +6% | +$4.02M |
|
14
Relay Therapeutics
RLAY
$4.25B
| $62.2M | 1.89% |
4,163,824
| – | – |
|
|
15
Zymeworks
ZYME
$1.81B
| $59.5M | 1.81% |
+7,568,573
| New | +$53.2M |
|
16
Alector
ALEC
$167M
| $37.4M | 1.14% |
4,056,548
| – | – |
|
|
NGM
17
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $32.3M | 0.98% |
6,435,518
+5,894,410
| +1,089% | +$36.9M |
|
|
18
Adicet Bio
ACET
$81.1M
| $31.8M | 0.97% |
+222,544
| New | +$55.5M |
|
19
Edgewise Therapeutics
EWTX
$4.39B
| $31.2M | 0.95% |
3,493,194
| – | – |
|
20
Tango Therapeutics
TNGX
$4.93B
| $30.5M | 0.93% |
4,201,414
| – | – |
|
21
Atea Pharmaceuticals
AVIR
$389M
| $29.7M | 0.91% |
6,184,861
| – | – |
|
22
Voyager Therapeutics
VYGR
$193M
| $29M | 0.88% |
4,753,907
| – | – |
|
23
Allogene Therapeutics
ALLO
$656M
| $28.2M | 0.86% |
4,488,200
| – | – |
|
|
24
Dyne Therapeutics
DYN
$3.97B
| $26.9M | 0.82% |
+2,322,384
| New | +$26.9M |
|
25
Nuvation Bio
NUVB
$2.05B
| $26.7M | 0.81% |
13,896,543
| – | – |
|
Similar funds
G
MC
BAM
CC
HFM
NO
ST
MFAM